House to scrutinize marketing of stents
Boston Scientific will submit internal files
As part of a federal inquiry into drug and medical-device marketing, Boston Scientific Corp. was asked by Congress last week to submit to investigators internal documents, marketing plans, and clinical data related to its top-selling product, the Taxus drug-coated stent. Full Story »
Posted by Michael Townes Watson
